Entera Bio financial statements

엔테라 바이오NASDAQ:ENTX · Nasdaq · Healthcare · sector #16
$2.53-3.44%
2026-10-06 close · prelim

Entera Bio's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$10M.

Reported results

Entera Bio notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q